Brookstone Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
JFG
Brookstone Capital Management's XBI Position: Q2 2026 in Review
Brookstone Capital Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 447% in Q2 2026, buying an estimated $1.77M and bringing the position to 16,038 shares worth $2.54M. The position accounts for 0.03% of the portfolio, ranked #457.
Brookstone Capital Management first reported a position in XBI in Q3 2020 and has held it in 13 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Brookstone Capital Management held 16,038 shares of State Street SPDR S&P Biotech ETF worth $2.54M as of Q2 2026.
- Brookstone Capital Management bought 13,108 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.77M.
- State Street SPDR S&P Biotech ETF made up 0.03% of Brookstone Capital Management's portfolio in Q2 2026, its #457 holding.
- Brookstone Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and has held it in 13 quarters since.
- 932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.